Comparable stake leader
NOMIS BAY LTD.
SEC ownership of HUMANIGEN, INC
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001293310.
Disclosed value leader
Cameron Durrant
Comparable rows
0/11
Latest evidence
18 Oct 2023
- Parsed ownership sources
-
3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
NOMIS BAY LTD.
Ranking: Comparable ownership first, then disclosed value
- Latest parsed ownership date
-
18 Oct 2023
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001293310
- Issuer location
- Short Hills, NJ
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
1 signal
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of HUMANIGEN, INC (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
NOMIS BAY LTD.
Disclosed value leader
Cameron Durrant
Comparable rows
0/11
Latest evidence
18 Oct 2023
3/4/5
Highest disclosed value: $3,664,344
11 rows are not safely comparable across share classes.
Showing 1-8 of 11 holder rows.
Quick read
Cameron Durrant has the largest disclosed position value at $3.66M.
0 of 11 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Cameron Durrant's linked filing trail.
Disclosed position value
Top 5
NOMIS BAY LTD.
$612.7K
Dale Chappell
$129.2K
Cameron Durrant
$3.66M
Timothy E. Morris
$2.72M
Adrian Kilcoyne
$2.43M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-8 of 11 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| NOMIS BAY LTD. |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$612,742
6,532,433 shares
|
— | 31 Dec 2020 |
| Dale Chappell |
3/4/5
Chief Scientific Officer, Director, 10%+ Owner
|
—
class O/S missing
|
$129,228
11,747,937 shares
|
— | 18 Oct 2023 |
| Cameron Durrant |
3/4/5
Chief Executive Officer, Director
|
—
class O/S missing
|
$3,664,344
808,906 shares
|
— | 27 Jul 2022 |
| Timothy E. Morris |
3/4/5
COO and CFO
|
—
class O/S missing
|
$2,719,631
600,360 shares
|
— | 27 Jul 2022 |
| Adrian Kilcoyne |
3/4/5
Chief Medical Officer
|
—
class O/S missing
|
$2,433,353
537,164 shares
|
— | 27 Jul 2022 |
| Edward P. Jordan |
3/4/5
Chief Commercial Officer
|
—
class O/S missing
|
$2,061,195
455,010 shares
|
— | 27 Jul 2022 |
| Yili Kevin Xie |
3/4/5
Director
|
—
class O/S missing
|
$377,884
83,418 shares
|
— | 27 Jul 2022 |
| Cheryl Buxton |
3/4/5
Director
|
—
class O/S missing
|
$354,980
78,362 shares
|
— | 27 Jul 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 05 Aug 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-11 of 11 reporting-owner rows connected to HUMANIGEN, INC. Open a relationship link for the CIK-to-CIK filing trail.
Rows
11
Largest Forms 3/4/5 holder
Cameron Durrant
Net 12M change
$0
Latest report
18 Oct 2023
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Cameron Durrant | Chief Executive Officer, Director | $3,664,344 | Mixed | 27 Jul 2022 | ||
| Timothy E. Morris | COO and CFO | $2,719,631 | Mixed | 27 Jul 2022 | ||
| Adrian Kilcoyne | Chief Medical Officer | $2,433,353 | Mixed | 27 Jul 2022 | ||
| Edward P. Jordan | Chief Commercial Officer | $2,061,195 | Mixed | 27 Jul 2022 | ||
| NOMIS BAY LTD. | 10%+ Owner | $612,742 | Mixed | 31 Dec 2020 | ||
| Yili Kevin Xie | Director | $377,884 | Mixed | 27 Jul 2022 | ||
| Cheryl Buxton | Director | $354,980 | Mixed | 27 Jul 2022 | ||
| Rainer J. Boehm | Director | $332,081 | Mixed | 27 Jul 2022 | ||
| John Hohneker | Director | $286,273 | Mixed | 27 Jul 2022 | ||
| Ronald Barliant | Director | $251,922 | Mixed | 27 Jul 2022 | ||
| Dale Chappell | Chief Scientific Officer, Director, 10%+ Owner | $129,228 | Filing P/S | 18 Oct 2023 |
Recent insider transactions for HUMANIGEN, INC
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* marks a reported price that did not pass the local price check.